Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Intestinal CYP3A Contribution to Drug Interactions With Envarsus XR Using Grapefruit Juice

NCT03916380 is registered in ClinicalTrials.gov with Shirley M. Tsunoda as lead sponsor.

NCT NCT03916380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03916380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Intestinal CYP3A Contribution to Drug Interactions With Envarsus XR Using Grapefruit Juice
Lead sponsor
Shirley M. Tsunoda
Phase
Observational
Overall status
Completed
Start date
October 25, 2019
Completion date
December 31, 2023
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug interaction food, kidney transplant; complications